Cs-131 Prostate Brachytherapy and Treatment Plan Parameters
Authors: Sutlief S and Wallner K
- Home
- About
- Brachytherapy
Patient Information
Clinician Information
Cesium 131 Products
- Theranostics
- Newsroom
- Investor Center
- Contact us
Is There a Decreased Duration of Acute Urinary and Bowel Symptoms after Prostate Brachytherapy with Cesium 131 Isotope?
Authors
DeFoe SG, et al.
- Published in journal:
International Journal of Radiation Oncology Biology Physics
September 1, 2008
Dr. DeFoe, from the University of Pittsburgh, reports on a series of 94 patients treated with Cesium-131 prostate brachytherapy. In agreement with other, similar, studies, the Cesium treated patients overcome brachytherapy-related urinary symptoms within six months. Their data suggests an early cessation of urinary side effects because of the short half-life of Cesium-131.
Related posts
Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution
Authors: C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel
Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131
Authors: Glaser SM, Chen KS, Benoit RM, Smith RP, Beriwal S.
Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point
Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi, L. Minsky, N. Kahan, W. Bodner, M. Garg, S. Kalnicki, C. Guha
Company
Brachytherapy
Theranostics
Company
©2023. All rights reserved. Terms & Privacy | Privacy Policy